Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Thursday, October 25, 2018

Email campaign : NHS CEO Simon Stevens re meta-bo

Re Email Campaign to UK NHS Chief Executive SIMON STEVENS.
To inform him of METABOLIC BODY/BREATH MALODOR and how the NHS could help.

A recent email campaign to inform Simon Stevens of metabolic body/breath malodor and inform him how the England NHS could help was undertaken recently.

Mr Stevens NHS web page details have since been removed.
( NHS profile link )

Reply from :
Celia Ingham Clark (profile link ) ( twitter )
Medical Director for Clinical Effectiveness at NHS England


The emails were forwarded to Celia Ingham Clark.
Here is her reply :

Thank you for your recent correspondence addressed to Simon Stevens, concerning metabolic body/breath malodour. I am responding on Simon’s behalf. In responding I have taken advice from the Deputy Chief Scientific Officer, Fiona Carragher, and from Dr Robin Lachmann who chairs our Clinical Reference Group on Metabolic Disorders. Both of these colleagues have relevant expertise and experience in metabolic disorders.
I understand that in some patients with abnormal body odour, the odour is due to elevated levels of trimethylamine (trimethylaminuria). This can either be caused by inherited genetic variants of the FMO3 enzyme or other, poorly understood, factors which reduce FMO3 enzyme activity. FMO3 is the liver enzyme that breaks down trimethylamine that is found in food. I gather that affected individuals have a distinctive, fishy body odour that can cause significant emotional and psychological distress to them. It must be a very distressing condition to live with.
Treatment is typically with a special diet +/- antibiotics to try and reduce the amount of trimethylamine entering the body from the gut. This treatment is normally effective, but is arduous to follow. At present there is no cure, but advances in genetic testing and gene therapy may mean that in future years there is hope for definitive treatment.
The single diagnostic testing centre in Sheffield carries out hundreds of tests each year for trimethylaminuria for patients from the whole of England. They changed their assay two years ago in order to revalidate and improve it. Previously a number of patients who had a positive result on the urine test were then shown NOT to have the FMO3 enzyme abnormality when they had a genetic test. The newer urine test is much more accurate.
Although most patients who complain of abnormal body odour have normal trimethylamine levels, and hence do not have trimethylaminuria, there are currently no other validated assays available to test for other metabolites which might be responsible.
There is information about fish odour syndrome on the public-facing NHS website, and this links to patient forums, as I expect you are aware. Thank you very much for bringing the condition to my attention. It must be frustrating to have symptoms for which the underlying cause and treatment have not been identified.
I hope that you find the information above helpful.
Yours sincerely,
Celia Ingham Clark
Medical Director for Clinical Effectiveness NHS England 

Reaction to reply

1. It's nice they at least researched the condition and got (tame) advice.
2. It's not useful advice.
3. Government agencies must be bound to reply to emails.
4. Many may have got this reply. That's ok, as it shows power in numbers.

It shows PERSONAL EMAILs to influential people, EMAIL CAMPAIGNS, and PETITIONS are worthwhile though may not feel like it.

It is vital that the community make INFLUENTIAL PEOPLE ./ AGENCIES aware of METABOLIC BODY/BREATH MALODOR, as they will not have heard of it and are the ones who make changes happen. EXTERNAL networking is the way forward.

A follow up email has been sent to Celia, including asking for a meeting.
We will keep you updated.

Other links :
Fiona Carragher NHS profile
Dr Robin Lachmann NHS profile

META-BO Help ratings :

Simon Stevens :
Will pass to another dept.
Hides email address.

Celia Ingham Clark :
Nice standard reply.
Looked into it.
But very limited help this time.
Maybe will see us in meeting ?

Fiona Carragher :
Unknown.
Has 'metabolic testing' background.

Dr Robin Lachmann :
Ptobably happy with status quo and new 'stricter' TMAU test ?


get New Posts by EMAIL : Enter your email address :



A EURORDIS and NORD Member Organization

0 comments:

Post a Comment